Breaking News & Top Stories
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has received a consensus rating of “Moderate Buy” from fourteen analysts following the company, according to data from Marketbeat.com. This rating reflects a diverse outlook,…
Portland General Electric (NYSE: POR) has received an updated price target of $49.00 from JPMorgan Chase & Co., a significant increase from the previous target of $47.00. This adjustment was…
Analysts at Wells Fargo & Company have begun coverage of Guardant Health (NASDAQ: GH) with a positive outlook. In a research report released on Monday, the brokerage assigned an “overweight”…
Masimo Corporation (NASDAQ: MASI) has been downgraded from a “buy” rating to a “hold” rating by analysts at Wall Street Zen, according to a report released on Saturday. This change…